Section 103 and Non-Obviousness Post-AIA
Navigating Timing Changes, Federal Court Treatment, and Secondary Considerations to Meet Patent Validity Requirements
Recording of a 90-minute premium CLE webinar with Q&A
This CLE webinar will provide guidance to patent counsel regarding the impact of the Leahy-Smith America Invents Act (AIA) on Section 103 and non-obviousness. The panel will offer best practices for meeting the non-obviousness requirement for patent validity.
Outline
- Section 103 and non-obviousness
- Recent court treatment
- Best practices for meeting the non-obviousness requirement
Benefits
The panel will review these and other key questions:
- How has the AIA impacted the determination of obviousness?
- How has the Federal Circuit treated the issue of non-obviousness?
- How has PTAB treated obviousness issues?
- What practices should counsel employ in order to meet the non-obviousness requirement?
Faculty

Thomas L. Irving
Partner
Finnegan Henderson Farabow Garrett & Dunner
Mr. Irving has 35 years of experience in the field of IP law. His practice includes due diligence, patent prosecution,... | Read More
Mr. Irving has 35 years of experience in the field of IP law. His practice includes due diligence, patent prosecution, reissue and reexamination, patent interferences, and counseling, including prelitigation, Orange Book listings of patents covering FDA-approved drugs, and infringement and validity analysis in the chemical fields, as well as litigation. He has served as lead counsel in many patent interferences.
Close
Erika H. Arner
Partner
Finnegan Henderson Farabow Garrett & Dunner
Ms. Arner practices patent prosecution management, client counseling, and litigation and helps clients establish... | Read More
Ms. Arner practices patent prosecution management, client counseling, and litigation and helps clients establish and grow patent portfolios, design and implement procedures to protect intellectual capital, and formulate company-wide IP strategies and policies. She co-authored a petition for a writ of certiorari in Bilski v. Doll and co-authored an amicus curiae brief to the federal circuit in In re Bilski.
Close